Visiting CPHI Barcelona?
Schedule a Meet

Alectinib D6

Product Information

Product Alectinib D6
CAT No. CS-P-08188
CAS No. 1616374-19-6
Status Available for Dispatch by 27-Sep-2023
Category Stable Isotopes
Mol. Wt. 488.65 mol/g
Mol. For. C30H28D6N4O2
Hazardous This is a Hazardous Compound

Product Description

Alectinib D6 is a deuterated form of Alectinib, a drug used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Alectinib D6 is a tyrosine kinase inhibitor that works by blocking the action of anaplastic lymphoma kinase (ALK), a protein that promotes the growth and spread of cancer cells. By inhibiting ALK, Alectinib D6 helps to slow down or stop the growth of cancer cells, thereby improving the patient's chances of survival. In terms of its chemical properties, Alectinib D6 is a white to off-white powder with a molecular weight of 555.67 g/mol. It is slightly soluble in water and has a melting point of 184-187°C. Alectinib D6 is also known by its chemical name, (R)-1-(2,6-dichloro-3-fluorophenyl)-2-[(1-methylpiperidin-4-yl)amino]-1-(4-(4-deuterium-labeled-phenyl)piperidin-4-yl)ethanol. Alectinib D6 is typically administered orally in capsule form, and the dosage and duration of treatment may vary depending on the patient's age, weight, and overall health status. Common side effects of Alectinib D6 include fatigue, nausea, diarrhea, and muscle pain. Patients taking this medication should also be monitored for potential liver and kidney problems, as well as any signs of allergic reactions or other serious adverse effects. Overall, Alectinib D6 is an important drug in the fight against NSCLC, and its deuterated form may offer enhanced therapeutic benefits compared to the non-deuterated version.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Alectinib
Therapeutic Anti-Cancer / Oncology
Smileys O=C1C(C2=CC=C(C#N)C=C2N3)=C3C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C4=CC(N5CCC(N6CCOCC6)CC5)=C(CC)C=C14
Hazardous Yes

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Alectinib D6 www.clearsynth.com 
 CAT : CS-P-08188 BATCH : CSC-WWW0757

 MF: C30H28D6N4O2
 CAS: 1616374-19-6
 Date of Anaysis: 22-Aug-2023
 Retest Date: 22-Jun-2026
MW: 488.65

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products